Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Axogen, Inc. market cap for the quarter ending 2026-07-27 was $2.21B, a 266.67% increase year-over-year.
Axogen, Inc. market cap for the quarter ending 2026-06-30 was $2.48B, a 398.79% increase year-over-year.
Axogen, Inc. market cap for the quarter ending 2026-04-24 was $2.09B, a 173.88% increase year-over-year.
Axogen, Inc. market cap for the quarter ending 2026-03-31 was $1.76B, a 109.27% increase year-over-year.
Axogen, Inc. market cap for fiscal 2026 was $2.21B.
Axogen, Inc. market cap for fiscal 2025 was $1.54B, a 112.30% increase from fiscal 2024.
Axogen, Inc. market cap for fiscal 2024 was $727.57M, a 147.02% increase from fiscal 2023.
Axogen, Inc. market cap for fiscal 2023 was $294.54M, a 30.47% decline from fiscal 2022.